An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program

HD 1119 prohibits pharmacy benefit managers (PBMs) from discriminating against hospitals and patients participating in the federal 340B drug discount program. The bill specifically bans PBMs from reimbursing 340B hospitals at lower rates than non-340B hospitals, charging extra fees for 340B participation, restricting network access based on 340B status, or requiring special identification for 340B drugs (except for Medicaid claims). It also prevents PBMs from steering patients away from 340B providers or imposing higher costs like extra copays for drugs obtained through these hospitals. This state-level bill directly affects 340B-covered hospitals (including community health centers and safety-net providers) and their patients by ensuring equitable access to discounted medications.